Journal of Clinical Endocrinology & Metabolism, Vol 79, 258-264, Copyright © 1994 by Endocrine Society

ARTICLES

Estradiol- and progesterone-related increases in the renin-aldosterone system: studies during ovarian stimulation and early pregnancy

JE Sealey, J Itskovitz-Eldor, S Rubattu, GD James, P August, I Thaler, J Levron and JH Laragh
Cardiovascular Center, Cornell University Medical College, New York, New York 10021.

To investigate the degree to which endogenous increases in estradiol (E2) and progesterone (P4) are associated with changes in the renin system, we studied eight patients undergoing ovarian stimulation for in vitro fertilization (FSH/human menopausal gonadotropin or clomiphene citrate for 5-11 days, followed by hCG). Three conceived and were followed for up to 62 days after hCG treatment. The others were followed until the end of the luteal phase. During the follicular phase, E2 increased 10-fold, PRA increased 2-fold, and absolute levels of E2 and P4 were positively correlated (r = 0.63; P < 0.05). After ovulation, which was induced by hCG, E2 fell by 50% (day 7), but there was a 50-fold increase in P4 and a further 5-fold increase in PRA. By day 14, E2 increased again in the women who conceived, to levels even higher than those in the follicular phase, and both P4 and PRA increased 2- to 3-fold between days 7 and 14. In contrast, E2, P4, and PRA returned toward baseline levels in the nonpregnant women. On day 21, E2, P4, and PRA remained very high in the pregnant women [E2, 2297 +/- 255 pg/mL (8430 pmol/L); P4, 103 +/- 22 pg/mL (328 pmol/L); PRA, 33 +/- 8 ng/mL.h (9.17 ng/L.s)]. During the luteal phase and early pregnancy, there was a positive relationship between PRA and P4 (r = 0.68; P < 0.05). There was also a positive relationship between PRA and E2 (r = 0.54; P < 0.05); compared to the follicular phase level, PRA was 4-fold higher in the luteal phase at any E2 level. Like renin, urinary aldosterone excretion (UA) increased 5-fold during the luteal phase (day 7) and by a further 3-fold between days 7 and 21 in the pregnant women, reaching very high levels [135 +/- 28 micrograms/day (375 nmol/day); n = 3]. PRA and UA positively correlated (r = 0.59; P < 0.08). Plasma angiotensinogen increased from 2146 +/- 283 ng angiotensin-I/mL (n = 8) to 3682 +/- 607 (n = 8) on day 7 and to 5353 +/- 799 (n = 3) on day 21. Urinary sodium excretion did not fall, and urinary potassium did not increase in coordination with the changes in renin and aldosterone. There was no hypokalemia. These results demonstrate marked increases in plasma renin and UA in coordination with increases in plasma E2 and P4 during ovarian stimulation and early pregnancy, and coordinated falls during luteolysis.(ABSTRACT TRUNCATED AT 400 WORDS)

This article has been cited by other articles:

				D. Z. I. Cherney, J. W. Scholey, D. C. Cattran, A. K. Kang, J. Zimpelmann, C. Kennedy, V. Lai, K. D. Burns, and J. A. Miller The effect of oral contraceptives on the nitric oxide system and renal function Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1539 - F1544. [Abstract] [Full Text] [PDF]

				N. S. Stachenfeld, D. L. Keefe, and H. S. Taylor Responses to a Saline Load in Gonadotropin-Releasing Hormone Antagonist-Pretreated Premenopausal Women Receiving Progesterone or Estradiol-Progesterone Therapy J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 386 - 394. [Abstract] [Full Text] [PDF]

				S. B. Ahmed, A. K. Kang, K. D. Burns, C. R. J. Kennedy, V. Lai, D. C. Cattran, J. W. Scholey, and J. A. Miller Effects of Oral Contraceptive Use on the Renal and Systemic Vascular Response to Angiotensin II Infusion J. Am. Soc. Nephrol., March 1, 2004; 15(3): 780 - 786. [Abstract] [Full Text] [PDF]

				M. Fischer, A. Baessler, and H. Schunkert Renin angiotensin system and gender differences in the cardiovascular system Cardiovasc Res, February 15, 2002; 53(3): 672 - 677. [Abstract] [Full Text] [PDF]

				M. Chidambaram, J. A. Duncan, V. S. Lai, D. C. Cattran, J. S. Floras, J. W. Scholey, and J. A. Miller Variation in the Renin Angiotensin System throughout the Normal Menstrual Cycle J. Am. Soc. Nephrol., February 1, 2002; 13(2): 446 - 452. [Abstract] [Full Text] [PDF]

				A. K. Kang, J. A. Duncan, D. C. Cattran, J. S. Floras, V. Lai, J. W. Scholey, and J. A. Miller Effect of oral contraceptives on the renin angiotensin system and renal function Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R807 - R813. [Abstract] [Full Text] [PDF]

				M. Tachibana, T. Kasukabe, Y. Kobayashi, T. Suzuki, S. Kinoshita, and Y. Matsushima Expression of Estrogen Receptor {alpha} and {beta} in the Mouse Cornea Invest. Ophthalmol. Vis. Sci., March 1, 2000; 41(3): 668 - 670. [Abstract] [Full Text]

				M. L Kuroski de Bold Estrogen, natriuretic peptides and the renin-angiotensin system Cardiovasc Res, March 1, 1999; 41(3): 524 - 531. [Abstract] [Full Text] [PDF]

				D. Manau, J. Balasch, V. Arroyo, W. Jiménez, F. Fábregues, R. Casamitjana, M. Creus, and J. A. Vanrell Circulatory Dysfunction in Asymptomatic in Vitro Fertilization Patients. Relationship with Hyperestrogenemia and Activity of Endogenous Vasodilators J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1489 - 1493. [Abstract] [Full Text]